Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Gan To Kagaku Ryoho ; 41(4): 517-22, 2014 Apr.
Article in Japanese | MEDLINE | ID: mdl-24743373

ABSTRACT

Gefitinib anderlotinib, which are epidermal growth factor receptor(EGFR)tyrosine kinase inhibitors(TKIs), have been usedfor the treatment of inoperable andrecurrent non-small cell lung cancer(NSCLC)patients. These drugs are known to cause a skin rash, one of the major side effects, at a high frequency. Biotin is a water-soluble vitamin, andit belongs to the vitamin B family. It is well known that biotin deficiency increases the risk of skin dermatitis. We administered biotin to four patients with skin rash, all of whom were treatedwith either gefitinib or erlotinib andwere unable to be treatedby a steroid ointment alone. In all patients, administration of biotin reduced the skin rash. Surprisingly, in 2 patients in whom EGFR-TKI therapy was discontinued because of the skin rash, the administration of biotin allowed for long-term gefitinib or erlotinib treatment. Biotin may be considereduseful for the treatment of skin rash causedby EGFR-TKIs. Further trials may be needed to confirm the value of biotin in this setting.


Subject(s)
Antineoplastic Agents/adverse effects , Biotin/therapeutic use , Erythema/drug therapy , Protein Kinase Inhibitors/adverse effects , Quinazolines/adverse effects , Aged , Aged, 80 and over , Antineoplastic Agents/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Erlotinib Hydrochloride , Erythema/chemically induced , Female , Gefitinib , Humans , Lung Neoplasms/drug therapy , Male , Prospective Studies , Protein Kinase Inhibitors/therapeutic use , Quinazolines/therapeutic use
3.
Gan To Kagaku Ryoho ; 39(9): 1443-5, 2012 Sep.
Article in Japanese | MEDLINE | ID: mdl-22996788

ABSTRACT

Were port a 51-year-old male left renal pelvic cancer patient with paclitaxel (PTX)-induced peripheral neuropathy, which was successfully treated with pregabalin. From June 2010, a gemcitabine/PTX (GP) regimen was used as third-line treatment. In order to relieve the PTX-induced peripheral neuropathy, pregabalin (75mg/day, at night) was administered from day 6 of the 16th course. Moreover, pregabalin was increased to 150mg/day from day 12 of the course. Sensory neurotoxicity after the administration of pregabalin was decreased from CTCAE (version 4. 0) grade 3 to 1 at day 19 of the course. Therefore, there is a possibility that the PTX -induced peripheral neuropathy may be improved by pregabalin administration. Further trials may be needed to confirm the value of pregabalin.


Subject(s)
Paclitaxel/adverse effects , Peripheral Nervous System Diseases/drug therapy , gamma-Aminobutyric Acid/analogs & derivatives , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Humans , Kidney Neoplasms/drug therapy , Kidney Neoplasms/pathology , Kidney Neoplasms/surgery , Male , Middle Aged , Neoplasm Staging , Paclitaxel/administration & dosage , Peripheral Nervous System Diseases/chemically induced , Pregabalin , gamma-Aminobutyric Acid/therapeutic use
4.
Gan To Kagaku Ryoho ; 39(5): 809-12, 2012 May.
Article in Japanese | MEDLINE | ID: mdl-22584337

ABSTRACT

When performing R-CHOP(rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)for diffuse large B-cell lymphoma(DLBCL), neurotoxicity of vincristine(VCR)is the serious dose-limiting factor.Pregabalin is one of the first-line treatments for painful diabetic peripheral neuropathy in many countries, and we have administered it to relieve the neurotoxicity associated with adverse effects of VCR in a DLBCL patient treated with the R-CHOP regimen.A 49-year-old man with kidney DLBCL had surgery performed.Afterward, the R-CHOP regimen was introduced.In order to relieve the neurotoxicity of VCR, pregabalin was used from day 8 in the second course.The severity of sensory neurotoxicity after the administration of pregabalin was improved from CTCAE(v4.0)grade 3 to grade 1.Therefore, there is a possibility that VCR-induced neurotoxicity is relieved by pregabalin.Further trials are needed to confirm the value of pregabalin.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Lymphoma, Large B-Cell, Diffuse/drug therapy , Peripheral Nervous System Diseases/prevention & control , gamma-Aminobutyric Acid/analogs & derivatives , Antibodies, Monoclonal, Murine-Derived/adverse effects , Antibodies, Monoclonal, Murine-Derived/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Cyclophosphamide/adverse effects , Cyclophosphamide/therapeutic use , Doxorubicin/adverse effects , Doxorubicin/therapeutic use , Humans , Kidney/pathology , Kidney/surgery , Lymphoma, Large B-Cell, Diffuse/pathology , Lymphoma, Large B-Cell, Diffuse/surgery , Male , Middle Aged , Neoplasm Staging , Prednisone/adverse effects , Prednisone/therapeutic use , Pregabalin , Rituximab , Tomography, X-Ray Computed , Vincristine/adverse effects , Vincristine/therapeutic use , gamma-Aminobutyric Acid/therapeutic use
6.
Plant Cell Physiol ; 49(3): 301-13, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18184692

ABSTRACT

With the original aim of surveying the role of exopolysaccharide (EPS) in Lotus-Mesorhizobium symbiosis, we carried out Tn5 mutagenesis of Mesorhizobium loti and obtained 32 mutants with defects in EPS biosynthesis. One of the mutants, HIA22, formed pseudonodules and failed to fix nitrogen with Lotus japonicus. However, complementation analysis unexpectedly revealed that the potential gene with the locus tag, mll2073, interrupted by Tn5 was responsible for neither normal EPS synthesis nor symbiosis. Further analysis uncovered that HIA22 had a genome deletion of approximately 20 kbp, resulting in the loss of two separate genes responsible for EPS biosynthesis and symbiosis. One gene with the locus tag, mll5669, was needed to synthesize normal EPS that fluoresced on medium containing Calcofluor and encoded a homolog of O-antigen acetyl transferase in Salmonella typhimurium. A specific mutant of mll5669, EMB-B58, successfully fixed nitrogen when infected onto L. japonicus. Another gene, mlr5647, was needed to establish fully functional nodules and encoded ornithine carbamoyl transferase [ArgF (EC 2.1.3.3)], which participates in arginine biosynthesis. A specific mutant of mlr5647, EMB-Y2, showed arginine auxotrophy and formed infection threads, but the nodules formed by this strain had few infected cells filled with bacteroids. These mutant phenotypes were complemented by supplementation of arginine or citrulline to bacterial or plant medium. EMB-Y2 represented a novel class of rhizobial arginine auxotrophs with symbiotic deficiency, and its phenotypes indicated that sufficient supply of citrulline or its derivative is essential for successful infection or for a stage in the infection process in Lotus-Mesorhizobium symbiosis.


Subject(s)
Gene Deletion , Genome, Bacterial , Lotus/microbiology , Ornithine Carbamoyltransferase/metabolism , Rhizobiaceae/enzymology , Rhizobiaceae/genetics , Symbiosis/physiology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cloning, Molecular , Gene Expression Regulation, Bacterial , Mutation , Ornithine Carbamoyltransferase/genetics , Root Nodules, Plant/cytology , Root Nodules, Plant/microbiology
7.
Nephrol Dial Transplant ; 21(10): 2768-74, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16820376

ABSTRACT

BACKGROUND: Using a rat model of renal failure with normal parathyroid hormone levels, we had demonstrated previously that bone formation decreased depending on the degree of renal dysfunction, and hypothesized that uraemic toxins (UTx) are associated with the development of low-turnover bone development, complicating renal failure. In this study, focusing on indoxyl sulphate (IS) as a representative UTx, we analysed the effect of an oral charcoal adsorbent AST-120, which removes uraemic toxins and their precursors from the gastrointestinal tract, on bone turnover. METHODS: AST-120 or vehicle was administered orally to model rats with uraemia and low turnover bone. Bone turnover was analysed by histomorphometry. Expression of osteoblast-related genes and oat-3 gene was analysed by reverse transcription polymerase chain reaction. RESULTS: In rats treated with vehicle, serum IS level increased with time after renal dysfunction, while bone formation decreased accompanied by down-regulation of the parathyroid/parathyroid-related peptide hormone receptor, alkaline phosphatase and osteocalcin genes. Administration of AST-120 inhibited the accumulation of IS in blood and ameliorated bone formation. Bone formation rate was 2.4 +/- 1.7 microm(3)/m(2)/year in controls given vehicle and was 11.7 +/- 2.4 microm(3)/m(2)/year in rats administered with AST-120 (P < 0.05). AST-120 treatment also reversed the down-regulation of osteoblast-related genes. Gene expression of oat-3 was detected in the tibia of rats. CONCLUSION: Administration of the oral charcoal adsorbent AST-120 decreases the osteoblast cytotoxicity of UTx including IS, and suppresses progression of low bone turnover in uraemic rats.


Subject(s)
Bone and Bones/drug effects , Carbon/pharmacology , Charcoal/pharmacology , Oxides/pharmacology , Uremia/metabolism , Administration, Oral , Alkaline Phosphatase/blood , Animals , Bone and Bones/metabolism , Calcium/blood , Calcium/urine , Carbon/administration & dosage , Charcoal/administration & dosage , Chromatography, High Pressure Liquid , Creatine/blood , Creatine/urine , Gene Expression/drug effects , Indican/blood , Male , Organic Anion Transporters, Sodium-Independent/genetics , Osteoblasts/drug effects , Osteoblasts/metabolism , Osteogenesis/drug effects , Oxides/administration & dosage , Parathyroid Hormone/metabolism , Phosphorus/blood , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Tibia/drug effects , Tibia/metabolism , Uremia/chemically induced
8.
J Bone Miner Metab ; 24(2): 172-5, 2006.
Article in English | MEDLINE | ID: mdl-16502128

ABSTRACT

Patients with end-stage renal disease (ESRD) develop various kinds of abnormalities in bone and mineral metabolism, widely known as renal osteodystrophy (ROD). Although the pathogenesis of ESRD may be similar in many patients, the response of the bone varies widely, ranging from high to low turnover. ROD is classified into several types, depending on the status of bone turnover, by histomorphometric analysis using bone biopsy samples [1,2]. In the mild type, bone metabolism is closest to that of persons with normal renal function. In osteitis fibrosa, bone turnover is abnormally activated. This is a condition of high-turnover bone. A portion of the calcified bone loses its lamellar structure and appears as woven bone. In the cortical bone also, bone resorption by osteoclasts is active, and a general picture of bone marrow tissue infiltration and the formation of cancellous bone can be observed. In osteomalacia, the bone surface is covered with uncalcified osteoid. This condition is induced by aluminum accumulation or vitamin D deficiency. The mixed type possesses characteristics of both osteitis fibrosa and osteomalacia. The bone turnover is so markedly accelerated that calcification of the osteoid cannot keep pace. In the adynamic bone type, bone resorption and bone formation are both lowered. While bone turnover is decreased, there is little osteoid. The existence of these various types probably accounts for the diversity in degree of renal impairment, serum parathyroid hormone (PTH) level, and serum vitamin D level in patients with ROD. However, all patients share a common factor, i.e., the presence of a uremic condition.


Subject(s)
Bone and Bones/metabolism , Chronic Kidney Disease-Mineral and Bone Disorder/pathology , Uremia/pathology , Aluminum/metabolism , Bone Diseases/metabolism , Bone Resorption , Glycoproteins/metabolism , Humans , Indican/metabolism , Osteitis Fibrosa Cystica/pathology , Osteoprotegerin , Parathyroid Hormone/blood , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Toxins, Biological , Uremia/metabolism , Vitamin D/metabolism
9.
Phytochemistry ; 66(5): 567-72, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15721949

ABSTRACT

Isolation and structure elucidation of three coumarins, murrayacoumarins A, B, and C, together with eight known coumarins, from the leaves of Murraya siamensis Craib collected in Thailand are described. Results of a primary screening of inhibitory effects of seven of these compounds on 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus early antigen activation in Raji cells are also presented.


Subject(s)
Antineoplastic Agents/pharmacology , Coumarins/chemistry , Coumarins/isolation & purification , Murraya/chemistry , Cell Line, Tumor , Coumarins/pharmacology , Humans , Magnetic Resonance Spectroscopy , Molecular Conformation , Plant Leaves/chemistry
10.
Kidney Int ; 63(5): 1671-80, 2003 May.
Article in English | MEDLINE | ID: mdl-12675842

ABSTRACT

BACKGROUND: Uremic toxins have been suggested to promote progression of chronic renal failure. We have shown that organic anion transporter-mediated uptake of uremic toxins induces oxidative stress in opossum kidney renal tubular cells overexpressing the transporter. Plasminogen activator inhibitor-1 (PAI-1) and nuclear factor-kappa B (NF-kappaB) are major factors known to promote tubulointerstitial fibrosis. The present study examined the signaling pathway that is activated by uremic toxins to induce PAI-1 and activate NF-kappaB in human renal proximal tubular cells (HK-2). METHODS: Uremic toxins in the form of organic anion were examined their ability to induce oxidative stress, PAI-1 gene expression, and NF-kappaB activation in HK-2. PAI-1 expression was measured by enzyme-linked immunosorbent assay (ELISA) and the Northern blotting. Human PAI-1 promoter activity was estimated by luciferase reporter gene (NKkappaB-luc) assay. NF-kappaB activation was measured by the pNFkappaB-luc reporter gene and electrophretic gel mobility shift assay. RESULTS: Among organic anion species tested, indoxyl sulfate and indoleacetic acid induced free radical production in HK-2. A nonspecific transporter inhibitor (probenecid) suppressed the IS-stimulated radical production. Indoxyl sulfate and indoleacetic acid dose dependently increased the expressions of PAI-1 mRNA and protein in these cells. The luciferase reporter gene assay revealed that indoxyl sulfate and indoleacetic acid dose dependently activated NF-kappaB and PAI-1 promoter. Activation of NF-kappaB was also confirmed by an electrophoretic gel mobility shift assay. Both antioxidant and NF-kappaB inhibitors dose dependently inhibited the activation of PAI-1 promoter by indoxyl sulfate. CONCLUSION: Uremic toxins induce free radical production by renal tubular cells and activate NF-kappaB which, in turn, up-regulates PAI-1 expression. Thus, progression of chronic renal failure may be promoted by PAI-1 up-regulation induced by uremic toxins.


Subject(s)
Indican/pharmacokinetics , Indoleacetic Acids/pharmacokinetics , Kidney Tubules, Proximal/cytology , NF-kappa B/metabolism , Plasminogen Activator Inhibitor 1/genetics , Anions/pharmacokinetics , Cells, Cultured , Free Radicals/metabolism , Gene Expression/drug effects , Humans , Kidney Failure, Chronic/physiopathology , Kidney Tubules, Proximal/metabolism , Oxidative Stress/drug effects , Promoter Regions, Genetic/physiology , Signal Transduction/drug effects , Toxins, Biological/pharmacology , Up-Regulation/drug effects , Uremia/physiopathology
11.
Br J Pharmacol ; 135(2): 555-63, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11815391

ABSTRACT

A direct effect of uraemic toxins in promoting progression of chronic renal disease has not been established. In this study, we investigated the toxic effects of organic anions which characteristically appeared in the patients with progressive renal disease on renal proximal tubular cells expressing human organic anion transporter (hOAT) 1. A renal proximal tubular cell line, opossum kidney (OK) cells, was transformed with hOAT1. Among the organic anions examined, hippuric acid, para-hydroxyhippuric acid, ortho-hydroxyhippuric acid, indoxyl sulphate and indoleacetic acid showed a high affinity for hOAT1 expressed in the OK cells. Indoxyl sulphate and indoleacetic acid concentration-dependently inhibited proliferation of the hOAT1-transformed cells. The h.p.l.c. analysis demonstrated that cellular uptake of these organic anions was significantly elevated in hOAT1-transformed cells. These organic anions also concentration-dependently stimulated cellular free radical production. The degrees of inhibition of cell proliferation and the stimulation of free radical production induced by the organic anions were significantly higher in the hOAT1-transformed cells than vector-transformed cells. The stimulatory effect of indoxyl sulphate on free radical production was abolished by anti-oxidants and probenecid. Less free radical production was observed in the hOAT1-transformed cells treated with p-hydroxyhippuric acid, o-hydroxyhippuric acid compared with indoxyl sulphate and indoleacetic acid. Hippuric acid had little effect on free radical production. Organic anions present in the serum of patients with progressive renal disease may cause proximal tubular injury via hOAT1-mediated uptake. The mechanism of cellular toxicity by these uraemic toxins involves free radical production. Thus, some uraemic toxins may directly promote progression of chronic renal disease.


Subject(s)
Kidney Tubules, Proximal/drug effects , Kidney Tubules, Proximal/pathology , Organic Anion Transport Protein 1/physiology , Toxins, Biological/pharmacology , Uremia/metabolism , Animals , Binding Sites , Cell Line , Cell Line, Transformed , Dose-Response Relationship, Drug , Free Radicals/metabolism , Growth Inhibitors/metabolism , Growth Inhibitors/pharmacology , Growth Inhibitors/physiology , Humans , Kidney Tubules, Proximal/metabolism , Opossums , Organic Anion Transport Protein 1/biosynthesis , Organic Anion Transport Protein 1/genetics , Organic Anion Transport Protein 1/metabolism , Rats , Toxins, Biological/metabolism , p-Aminohippuric Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...